Skip to main content
OptiNose, Inc. (OPTN)
NASDAQ: OPTN · Real-Time Price · USD
0.367
+0.028 (8.32%)
At close: Nov 20, 2024, 4:00 PM
0.380
+0.013 (3.54%)
After-hours: Nov 20, 2024, 6:46 PM EST

OptiNose Revenue

OptiNose had revenue of $20.44M in the quarter ending September 30, 2024, with 3.10% growth. This brings the company's revenue in the last twelve months to $75.67M, up 5.13% year-over-year. In the year 2023, OptiNose had annual revenue of $70.99M, down -6.93%.

Revenue (ttm)
$75.67M
Revenue Growth
+5.13%
P/S Ratio
0.66
Revenue / Employee
$573,273
Employees
132
Market Cap
55.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202370.99M-5.29M-6.93%
Dec 31, 202276.28M1.62M2.18%
Dec 31, 202174.65M25.54M51.99%
Dec 31, 202049.12M14.49M41.83%
Dec 31, 201934.63M27.57M390.18%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Precision BioSciences 75.10M
Apyx Medical 48.54M
BGM Group 29.87M
Kronos Bio 9.87M
Lucid Diagnostics 4.19M
vTv Therapeutics 1.00M
CollPlant Biotechnologies 689.00K
Revenue Rankings

OPTN News

More News